Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, is making waves in the healthcare sector with its cutting-edge approach to drug development. Based in New Haven, Connecticut, Arvinas focuses on..
Evolus, Inc. (NASDAQ: EOLS), a prominent name in the healthcare sector, particularly within the specialized field of drug manufacturing, is drawing significant attention from investors. The company, headquartered in Newport..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is making waves with its impressive array of plasma-derived protein therapeutics. With a robust market cap of $453.14 million,..
Cel-Sci Corporation (NASDAQ: CVM) is a name that might not be on every investor’s radar, but its potential for staggering returns certainly warrants a closer look. With a potential upside..
CeriBell, Inc. (NASDAQ: CBLL) is capturing attention in the healthcare sector, particularly within the bustling medical devices industry. With a market capitalization of $684.19 million, this U.S.-based company is pioneering..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing investor enthusiasm with its dynamic positioning in the biotechnology sector, specifically within the healthcare industry. With a market capitalization of $920.36 million, this..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline and a significant potential upside that could appeal to growth-focused..
Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is capturing investor attention with a staggering potential upside of 213.49%. Specializing in the development of..
Inventiva S.A. – American Depositary Shares (IVA), a French biopharmaceutical company specializing in innovative treatments for complex diseases, is capturing investor attention with its staggering potential upside of 261.76%. This..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a rising star in the biotechnology sector, has become a focal point for investors seeking substantial growth opportunities. With an impressive potential upside of 285.82%,..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, has captured the attention of investors with its potential 64.71% upside. Specializing in advanced wound care, surgical,..
For investors seeking opportunities in the biotechnology sector, Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling case with its promising pipeline of T cell therapies and a significant potential upside..
Investors looking for opportunities in the biotechnology sector may find Niagen Bioscience, Inc. (NASDAQ: NAGE) a compelling prospect. With its focus on developing innovative healthy aging products, Niagen is positioned..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical firm based in Cambridge, Massachusetts, specializes in developing innovative brain health medicines. With a market capitalization of approximately $576.13 million, Sage sits at..
Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor attention with its potential upside of 89.74%, a figure that stands out in the healthcare sector’s competitive landscape. As a key player..
In the dynamic world of biotechnology, Maze Therapeutics, Inc. (NASDAQ: MAZE) emerges as a compelling opportunity for investors seeking promising growth potential. With its focus on developing precision medicines for..
Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with its promising pipeline in the biotech sector. As a development-stage biopharmaceutical company, Verastem primarily focuses on innovative cancer treatments,..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing the attention of investors in the biotechnology sector, thanks to its promising pipeline and potential for significant gains. With a market capitalization of..
COMPASS Pathways Plc (NASDAQ: CMPS) is making waves in the healthcare sector, particularly among investors focused on groundbreaking advancements in mental health treatments. Based in the United Kingdom, this biotechnology..
Investors in the biotechnology sector are always on the lookout for companies with groundbreaking potential, and Precigen, Inc. (NASDAQ: PGEN) is currently on the radar for its trailblazing approaches in..
